In this article, we will discuss the 12 Best Value Stocks to Buy Right Now.
On June 26, EY-Parthenon’s Greg Daco appeared on CNBC’s ‘The Exchange’ to discuss the economy’s standing. Daco explained that the Fed’s monetary policy stance is currently slightly restrictive, placing a degree of restraint on the economy. He argued that the inflation the country is experiencing is not driven by high demand but rather by supply-side pressures, such as elevated energy prices and the strain of AI-driven demand on limited resources, which have pushed up prices for computers and electronics. Because these are not pressures the Fed is well-equipped to manage through standard rate adjustments, Daco anticipates that the Fed will continue to hold rates steady, even with inflation running at double the Fed’s 2% target.
Addressing the broader economic health of the nation, Daco discussed the income squeeze currently affecting many Americans. He noted that data for May shows that income, when adjusted for taxes and inflation, is essentially not growing, leading to a gradual erosion of spending power. While he does not believe that the economy is entering a recession or immediate slowdown, he emphasized that this erosion of spending power is capping the potential growth of consumer spending. Daco explained that although lower energy prices may help reduce inflation in H2 of the year, one of the primary pillars of consumer spending (inflation-adjusted wages) is currently in contraction. Ultimately, he concluded that while the US economy is still moving forward, these underlying fragilities in the pillars of growth provide the key reason why the Fed will likely decide to remain on hold.
Our Methodology
We used screeners to identify stocks that are trading below a forward P/E of 15, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Note: All data was sourced on June 29.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
12 Best Value Stocks to Buy Right Now
12. Eni S.p.A. (NYSE:E)
Number of Hedge Fund Holders: 14
Eni S.p.A. (NYSE:E) is one of the best value stocks to buy right now. On June 29, Eni announced an agreement to acquire a 32% stake in three unconventional gas blocks within Argentina’s Vaca Muerta shale formation. Once regulatory approvals are secured, the assets will be jointly owned by YPF, Eni, and XRG. This investment is designed to supply gas to the Argentina LNG project, an integrated development that aims to export 12 million metric tons of LNG annually using two floating units.
The deal aligns with Eni’s strategy to build integrated value chains by combining upstream production with global LNG marketing. Company leadership emphasized that the partnership uses their expertise in floating LNG technology to convert Vaca Muerta’s vast shale resources into competitive exports for the international market.
This collaboration marks a significant milestone for Argentina’s energy ambitions as it seeks to monetize its unconventional resources. By bringing together major industry players, the project aims to establish Argentina as a long-term supplier in the global gas market, addressing the rising demand for flexible LNG supply through large-scale infrastructure development.
Eni S.p.A. (NYSE:E) operates as an integrated energy company across Italy, the rest of Europe, the United States, Asia, Africa, and international markets.
11. Sun Life Financial Inc. (NYSE:SLF)
Number of Hedge Fund Holders: 17
Sun Life Financial Inc. (NYSE:SLF) is one of the best value stocks to buy right now. On June 16, Sun Life US and Medzown announced a collaboration to increase access to clinical trials for employees of self-insured employers dealing with cancer and complex conditions like orthopedic/musculoskeletal issues. By using Medzown’s AI-powered predictive analytics, Sun Life’s stop-loss clients can identify members at critical diagnostic stages and connect them with advanced therapeutic options and clinical trials.
The partnership aims to address the rising financial burden of high-cost claims, which average over $250,000 for cancer treatments, by providing precision medicine support and personalized patient navigation. A team of scientists and navigators will work directly with members and their care teams, acting as an extension of existing benefits to ensure a supported path to effective, cutting-edge therapies.
This initiative expands Sun Life Financial Inc.’s (NYSE:SLF) suite of health solutions, which already includes clinical reviews and expert cancer second opinions. By proactively managing complex diagnoses, the collaboration seeks to improve patient health outcomes while simultaneously reducing long-term specialty drug cost exposure for self-funded employers.
Sun Life Financial Inc. (NYSE:SLF) is a financial services company that provides asset management, wealth, insurance, and health solutions to individual and institutional customers internationally.
